Comments on "Importance of Normalization of CA19-9 Levels After Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer''

被引：0
|
作者：
Xu, Hua-Xiang [1 ,2 ,3 ,4 ]
Li, Shuo [1 ,2 ,3 ]
Xu, Shuai-Shuai [1 ,2 ,3 ,4 ]
Liu, Liang [1 ,2 ,3 ,4 ]
Yu, Xian-Jun [1 ,2 ,3 ,4 ]
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[3] Shanghai Pancreat Canc Inst, Shanghai, Peoples R China
[4] Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China
来源：
ANNALS OF SURGERY | 2021年 / 274卷 / 06期
关键词：
RESECTION;
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E800 / E801
页数：2
相关论文
共 38 条
  • [1] The prognostic value of CA19-9 response after neoadjuvant therapy in patients with pancreatic cancer: a systematic review and pooled analysis
    Ye, Chen
    Sadula, Abuduhaibaier
    Ren, Siqian
    Guo, Xin
    Yuan, Meng
    Yuan, Chunhui
    Xiu, Dianrong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (06) : 731 - 740
  • [2] Serum CA19-9 Response to Neoadjuvant Therapy Predicts Tumor Size Reduction and Survival in Pancreatic Adenocarcinoma
    Al Abbas, Amr I.
    Zenati, Mazen
    Reiser, Caroline J.
    Hamad, Ahmad
    Jung, Jae Pil
    Zureikat, Amer H.
    Zeh, Herbert J., III
    Hogg, Melissa E.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (06) : 2007 - 2014
  • [3] Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim, Young Choon
    Kim, Hong Joo
    Park, Jung Ho
    Park, Dong Il
    Cho, Yong Kyun
    Sohn, Chong Il
    Jeon, Woo Kyu
    Kim, Byung Ik
    Shin, Jun Ho
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (12) : 1869 - 1875
  • [4] CA19-9 in Potentially Resectable Pancreatic Cancer: Perspective to Adjust Surgical and Perioperative Therapy
    Hartwig, Werner
    Strobel, Oliver
    Hinz, Ulf
    Fritz, Stefan
    Hackert, Thilo
    Roth, Constanze
    Buechler, Markus W.
    Werner, Jens
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (07) : 2188 - 2196
  • [5] CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer
    Williams, Jennifer L.
    Kadera, Brian E.
    Nguyen, Andrew H.
    Muthusamy, V. Raman
    Wainberg, Zev A.
    Hines, O. Joe
    Reber, Howard A.
    Donahue, Timothy R.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (07) : 1331 - 1342
  • [6] Elevated CEA and CA19-9 serum levels independently predict advanced pancreatic cancer at diagnosis
    van Manen, Labrinus
    Groen, Jesse V.
    Putter, Hein
    Vahrmeijer, Alexander L.
    Swijnenburg, Rutger-Jan
    Bonsing, Bert A.
    Mieog, J. Sven D.
    BIOMARKERS, 2020, 25 (02) : 186 - 193
  • [7] Prognostic Impact of CA 19-9 on Outcome after Neoadjuvant Chemoradiation in Patients with Locally Advanced Pancreatic Cancer
    Combs, Stephanie E.
    Habermehl, Daniel
    Kessel, Kerstin A.
    Bergmann, Frank
    Werner, Jens
    Naumann, Patrick
    Jaeger, Dirk
    Buechler, Markus W.
    Debus, Juergen
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (08) : 2801 - 2807
  • [8] Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma
    Zhang, Shun
    Wang, Yi-Ming
    Sun, Chuan-Dong
    Lu, Yun
    Wu, Li-Qun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (23) : 3750 - 3753
  • [9] Clinical value of serum CA19-9 levels in evaluating resectability of pancreatic carcinoma
    Shun Zhang
    World Journal of Gastroenterology, 2008, (23) : 3750 - 3753
  • [10] CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX
    Tanaka, Masayuki
    Heckler, Max
    Mihaljevic, Andre L.
    Sun, Huihui
    Klaiber, Ulla
    Heger, Ulrike
    Buechler, Markus W.
    Hackert, Thilo
    EJSO, 2019, 45 (08): : 1453 - 1459
1234